Charles Swanton

Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory

United Kingdom

SCHOLARLY PAPERS

2

DOWNLOADS

108

SSRN CITATIONS

1

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

Collateral Damage: The Impact on Cancer Outcomes of the COVID-19 Pandemic

Number of pages: 29 Posted: 20 May 2020
Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Public Health England - National Cancer Registration and Analysis Service, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology, Royal Marsden NHS Foundation Trust - Urology Unit, Royal Marsden NHS Foundation Trust - Department of Anaesthesia, Oxford University Hospitals NHS Foundation Trust - Department of Colorectal Surgery, Royal Marsden NHS Foundation Trust - Department of Anaesthesia, Royal Marsden NHS Foundation Trust - Department of Anaesthesia, Royal Marsden NHS Foundation Trust - Lung Cancer Unit, Royal Marsden NHS Foundation Trust, Royal Marsden NHS Foundation Trust - Department of Clinical Oncology, Royal Marsden NHS Foundation Trust - RM Partners, University of Cambridge - Department of Public Health and Primary Care, Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Imperial College Healthcare NHS Trust - Department of Clinical Oncology, Public Health England - National Cancer Registration and Analysis Service, Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology and Institute of Cancer Research (ICR) - Division of Genetics and Epidemiology
Downloads 56 (401,620)

Abstract:

Loading...

cancer; diagnosis; surgery; COVID-19 pandemic; diagnostic delay; healthcare resource; life years gained; survival

2.

Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue

Number of pages: 53 Posted: 17 Jun 2019
Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Roche Tissue Diagnostics, Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Roche Tissue Diagnostics, Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Roche Sequencing Solutions, Institut de Cancérologie de Lorraine - Biopathology Service, Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Roche Tissue Diagnostics, Royal Marsden Hospital, Royal Marsden Hospital, Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute, Roche Tissue Diagnostics, Roche Tissue Diagnostics, Roche Tissue Diagnostics, Roche Sequencing Solutions, Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Aarhus University Hospital - Department of Molecular Medicine, Aarhus University Hospital - Department of Molecular Medicine, Aarhus University Hospital - Department of Molecular Medicine, Royal Marsden NHS Foundation Trust, University College London - Cancer Research UK Lung Cancer Centre of Excellence, Royal Marsden NHS Foundation Trust, Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory, Roche Tissue Diagnostics and Francis Crick Institute - Cancer Evolution and Genome Instability Laboratory
Downloads 52 (415,345)

Abstract:

Loading...

Tumor Sequencing, Molecular Profiling, Next Generation Sequencing, Cancer Genetics, Cancer Biomarkers